Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Target Raised at UBS Group

Sabra Healthcare REIT (NASDAQ:SBRA) had its price objective hoisted by UBS Group from $20.00 to $22.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the real estate investment trust’s stock. UBS Group‘s price target suggests a potential upside of 4.91% from the company’s previous close.

A number of other analysts have also commented on the stock. Deutsche Bank restated a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Huntington assumed coverage on Sabra Healthcare REIT in a research note on Monday, November 2nd. They set a “strong-buy” rating on the stock. Citigroup restated a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Citizens Jmp raised their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a report on Wednesday, July 22nd. Finally, Mizuho set a $21.00 price target on shares of Sabra Healthcare REIT in a report on Monday, August 31st. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $21.67.

Sabra Healthcare REIT Trading Down 1.6%

SBRA stock traded down $0.35 during midday trading on Wednesday, hitting $20.97. The stock had a trading volume of 1,761,851 shares, compared to its average volume of 2,688,708. The firm has a market cap of $5.49 billion, a P/E ratio of 74.90, a price-to-earnings-growth ratio of 1.95 and a beta of 0.68. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.86. The business has a fifty day moving average price of $19.90 and a two-hundred day moving average price of $20.02. Sabra Healthcare REIT has a 1-year low of $17.53 and a 1-year high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.05). The business had revenue of $249.57 million for the quarter, compared to the consensus estimate of $236.64 million. Sabra Healthcare REIT had a net margin of 7.78% and a return on equity of 2.55%. The firm’s revenue for the quarter was up 31.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.38 EPS. On average, sell-side analysts predict that Sabra Healthcare REIT will post 1.52 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CEO Richard Matros sold 200,000 shares of Sabra Healthcare REIT stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the sale, the chief executive officer owned 1,657,686 shares in the company, valued at $34,529,599.38. The trade was a 10.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.09% of the stock is owned by insiders.

Hedge Funds Weigh In On Sabra Healthcare REIT

Several institutional investors and hedge funds have recently added to or reduced their stakes in SBRA. Lasalle Investment Management Securities LLC increased its holdings in shares of Sabra Healthcare REIT by 8.2% during the first quarter. Lasalle Investment Management Securities LLC now owns 3,824,622 shares of the real estate investment trust’s stock valued at $73,547,000 after acquiring an additional 290,405 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in Sabra Healthcare REIT by 7.8% in the first quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust’s stock valued at $71,640,000 after acquiring an additional 269,793 shares during the period. Russell Investments Group Ltd. lifted its stake in shares of Sabra Healthcare REIT by 70.2% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,856,730 shares of the real estate investment trust’s stock worth $36,615,000 after purchasing an additional 765,527 shares during the period. Rush Island Management LP bought a new stake in shares of Sabra Healthcare REIT during the 1st quarter valued at $30,735,000. Finally, Sound Income Strategies LLC increased its position in Sabra Healthcare REIT by 8.3% in the third quarter. Sound Income Strategies LLC now owns 1,051,751 shares of the real estate investment trust’s stock worth $19,815,000 after buying an additional 80,453 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.